Ho Yau Chan - 18 Mar 2026 Form 3 Insider Report for Regencell Bioscience Holdings Ltd (RGC)

Role
Financial Controller
Signature
/s/ James Wai Hong Chung, attorney-in-fact
Issuer symbol
RGC
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 09:15:05 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CHAN HO YAU Financial Controller C/O 9/F CHINACHEM LEIGHTON PLAZA, 29 LEIGHTON ROAD, CAUSEWAY BAY, HONG KONG, CHINA /s/ James Wai Hong Chung, attorney-in-fact 18 Mar 2026 0002112761

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RGC Stock option (right to purchase) 18 Mar 2026 Ordinary shares, par value $0.00001 740,278 $0.2500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted the option on June 9, 2021 pursuant to the Issuer's 2021 Share Option Plan. The option vested equally each of the four anniversaries of the closing of the Issuer's initial public offering and is now fully vested. The expiration date is 10 years from the date the options become vested.

Remarks:

Exhibit 24 - Power of Attorney